Aristeidis Katsanos
Population Health Research Institute · Population Health Research Institute, Hamilton Health Sciences, McMaster University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aristeidis Katsanos as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:25 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07511543 · Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke ThrombectomyPopulation Health Research Institute · not yet recruiting · Ischemic Stroke · principal investigator
- N/ANCT07367633 · Head of Bed After Ischemic Stroke Thrombectomy (HoBIT)Population Health Research Institute · recruiting · Large Vessel Occlusion, Stroke, Ischemic Stroke · principal investigator
- Ph3NCT06587737 · Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral HemorrhagePopulation Health Research Institute · not yet recruiting · Colchicine, ICH - Intracerebral Hemorrhage, Stroke · principal investigator
- Ph2NCT05159219 · Colchicine for the Prevention of Vascular Events After an Acute Intracerebral HemorrhagePopulation Health Research Institute · completed · Intracranial Hemorrhages · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:25 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension.Br J Ophthalmol · 201352 citationsRCR 3.0
- Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study.Sci Rep · 201843 citationsRCR 3.4
- Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma.J Clin Pharmacol · 201227 citationsRCR 1.5
- Long-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucoma.J Glaucoma · 201422 citationsRCR 1.4
- 22 citationsRCR 1.7
- Plasma and aqueous humour levels of ghrelin in open-angle glaucoma patients.Clin Exp Ophthalmol · 201120 citationsRCR 0.8
- Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke.Neurology · 201819 citationsRCR 0.8
- Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients.Expert Opin Pharmacother · 201816 citationsRCR 1.3
- Eligibility for mechanical thrombectomy in acute ischemic stroke: A phase IV multi-center screening log registry.J Neurol Sci · 201615 citationsRCR 0.6
- 13 citationsRCR 3.1